Page 16 - Mass General Brigham - Innovators Guide 1.0
P. 16

16    INNO V AT O RS GUIDE  |  M ASS GENERAL BRIGH AM

           2
                                               About the

            2                                  Innovation team














            Mass General Brigham Ventures and                                     An important and growing Innovation capability is accelerating the

            Translational Innovation                                              translation of promising research breakthroughs. This includes the
                                                                                  Translational Innovation Fund (TIF) which provides resources to validate
                                                                                  and add value to highly promising commercially oriented Mass General
            Mass General Brigham Ventures is an internal, early stage venture capital   Brigham research. The TIF engages with promising opportunities that are
            fund (previously known as Partners Innovation Fund). It was created in   expected to significantly increase the value of license and/or spin-offs
            2008 to accelerate the commercial application of Mass General Brigham   based on the research. Resources typically range from $500,000 to
            research breakthroughs. The Fund has grown to several hundred million   $2 million and per project and are largely expended outside the system to
            dollars under management and created dozens of portfolio companies that   validate and enhance the technology. A key goal is to substantially increase
            have raised billions of dollars of follow-on capital. It is one of the highest   the value of the Mass General Brigham technology while it is still in its
            performing academically managed venture funds in the United States. It   pre-commercial stage. 25% of the net system proceeds from the ultimate
            co-invests with the industry’s top life science venture funds.
                                                                                  commercialization are returned to the TIF to provide support for future
            Fund staff are active in company creation and support its portfolio   translational opportunities.
            companies through their entire lifecycles from creation to exit. The Fund   Other translational capabilities include the Innovation Discovery Grant
            has first access to disclosed inventions from the Mass General Brigham   (IDG) program and the Boston Biomedical Innovation Center (B-BIC), both
            system and works side-by-side with principal investigators across the   managed by Innovation.
            network. Investments are initially directed at the seed and Series A
            stages, which attracts management talent and additional capital to the    For more information, please contact Roger Kitterman, Vice President,
            funded companies.                                                     Venture, rkitterman@partners.org.

            The $30 million AI and Digital Investment Fund (AIDIF) was recently   Fund details are at: https://www.partnersinnovationfund.com/
            launched and is part of Mass General Brigham Ventures. It is described
            in chapter 8 for more information on AIDIF.
   11   12   13   14   15   16   17   18   19   20   21